NFC
AST
Northeast Financial Consultants’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-577,262
| Closed | -$358K | – | 324 |
|
|
2018
Q4 | $358K | Buy |
+577,262
| New | +$358K | 0.05% | 127 |
|
|
2018
Q3 | – | Sell |
-732,265
| Closed | -$988K | – | 185 |
|
|
2018
Q2 | $988K | Hold |
732,265
| – | – | 0.3% | 47 |
|
|
2018
Q1 | $1.06M | Hold |
732,265
| – | – | 0.36% | 43 |
|
|
2017
Q4 | $1.65M | Hold |
732,265
| – | – | 0.55% | 34 |
|
|
2017
Q3 | $2.49M | Hold |
732,265
| – | – | 0.91% | 23 |
|
|
2017
Q2 | $2.6M | Hold |
732,265
| – | – | 1.02% | 21 |
|
|
2017
Q1 | $2.49M | Hold |
732,265
| – | – | 1.04% | 19 |
|
|
2016
Q4 | $3.37M | Hold |
732,265
| – | – | 1.5% | 12 |
|
|
2016
Q3 | $3.11M | Buy |
732,265
+697,239
| +1,991% | +$2.96M | 1.31% | 18 |
|
|
2016
Q2 | $84K | Buy |
+35,026
| New | +$84K | 0.04% | 146 |
|